Immune Disease and Cancer

Infection, cancer and autoimmune diseases appear to have little in common. However, a newly discovered white blood cell type called TH17 may have major roles in all three types of diseases.

These cells normally fight infection but also appear to promote destructive inflammation in autoimmune disease or inflammation that assists cancer cell growth.

Burnet Institute is trying to find out why the immune system attacks normal cells it should ignore in rheumatoid arthritis and lupus, but in cancer ignores the cells it should attack, and how is it that infectious agents avoid immune destruction.

Donate today!

Use my gift where the need is greatest

Current Projects

  • Fc Receptor Targeted Treatments in Inflammation and Allergy

  • A unique approach to anti-inflammatory immune therapy

  • Age-related immune dysfunction may underpin poor COVID-19 outcomes in the elderly

  • Antibody mAbs to destroy infection: engineering the next generation treatments

  • Barriers to hepatocellular carcinoma screening uptake in Victoria

  • Discovery of new treatments for myeloma and myelogenous leukemia

  • Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency

  • New approaches to the treatment of lupus

  • Stellabody® Technology in Infectious Disease – COVID-19 and beyond

  • Stellabody® Technology in Cancer Therapy

  • Understanding the connection between inflammation and cancer